Discovery and Biosynthetic Studies of a Highly Reduced Cinnamoyl Lipid, Tripmycin A, from an Endophytic Streptomyces sp.

Jieqian Kong,Chengshuang Huang,Yi Xiong,Baihuan Li,Wenping Kong,Wangyang Liu,Zhouke Tan,Dian Peng,Yanwen Duan,Xiangcheng Zhu
DOI: https://doi.org/10.1021/acs.jnatprod.3c00199
IF: 5.1
2023-07-18
Journal of Natural Products
Abstract:A <i>Tripterygium wilfordii</i> endophyte, <i>Streptomyces</i> sp. CB04723, was shown to produce an unusually highly reduced cytotoxic cinnamoyl lipid, tripmycin A (<b>1</b>). Structure-activity relationship studies revealed that both the cinnamyl moiety and the saturated fatty acid side chain are indispensable to the over 400-fold cytotoxicity improvement of <b>1</b> against the triple-negative breast cancer cell line MDA-MB-231 compared to 5-(2-methylphenyl)-4-pentenoic acid (<b>2</b>). Bioinformatical analysis, gene inactivation, and overexpression revealed that Hxs15 most likely acted as an enoyl reductase and was involved with the side chain reduction of <b>1</b>, which provides a new insight into the biosynthesis of cinnamoyl lipids.
plant sciences,chemistry, medicinal,pharmacology & pharmacy
What problem does this paper attempt to address?